NO20043576L - Pharmaceutical formulation comprising melatonin - Google Patents
Pharmaceutical formulation comprising melatoninInfo
- Publication number
- NO20043576L NO20043576L NO20043576A NO20043576A NO20043576L NO 20043576 L NO20043576 L NO 20043576L NO 20043576 A NO20043576 A NO 20043576A NO 20043576 A NO20043576 A NO 20043576A NO 20043576 L NO20043576 L NO 20043576L
- Authority
- NO
- Norway
- Prior art keywords
- melatonin
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL149377A IL149377A (en) | 2002-04-28 | 2002-04-28 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
PCT/IL2003/000240 WO2003086352A1 (en) | 2002-04-08 | 2003-03-20 | Pharmaceutical formulation comprising melatonin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20043576L true NO20043576L (no) | 2004-12-22 |
NO332525B1 NO332525B1 (no) | 2012-10-08 |
Family
ID=29227410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043576A NO332525B1 (no) | 2002-04-28 | 2004-08-27 | Farmasoytisk formulering omfattende melatonin |
Country Status (30)
Country | Link |
---|---|
US (1) | US20050175692A1 (no) |
EP (1) | EP1494650B1 (no) |
JP (1) | JP2005527583A (no) |
KR (1) | KR101000624B1 (no) |
CN (1) | CN100386070C (no) |
AR (1) | AR039232A1 (no) |
AT (1) | ATE507831T1 (no) |
AU (1) | AU2003227304B2 (no) |
BR (1) | BR0308762A (no) |
CA (1) | CA2477516C (no) |
DE (1) | DE60336999D1 (no) |
DK (1) | DK1494650T3 (no) |
EA (1) | EA007954B1 (no) |
ES (1) | ES2366116T3 (no) |
GT (1) | GT200300064A (no) |
HK (1) | HK1075616A1 (no) |
HN (1) | HN2003000115A (no) |
IL (1) | IL149377A (no) |
IS (1) | IS2858B (no) |
MX (1) | MXPA04009893A (no) |
NO (1) | NO332525B1 (no) |
NZ (1) | NZ536298A (no) |
PE (1) | PE20040161A1 (no) |
PL (1) | PL209922B1 (no) |
PT (1) | PT1494650E (no) |
TW (1) | TW200305404A (no) |
UA (1) | UA86924C2 (no) |
UY (1) | UY27753A1 (no) |
WO (1) | WO2003086352A1 (no) |
ZA (1) | ZA200407563B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2551637A1 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
TW200626137A (en) * | 2004-12-13 | 2006-08-01 | Takeda Pharmaceuticals Co | Preventive or therapeutic agent for sleep disorder |
US20060198872A1 (en) * | 2005-03-07 | 2006-09-07 | Chioma Ikonte | Plant based dietary supplement for improving the duration and quality of sleep |
KR20070070307A (ko) * | 2005-08-24 | 2007-07-04 | 에스에스 세야쿠 가부시키 가이샤 | 수면 개선 의약 조성물 |
CN1299680C (zh) * | 2005-08-29 | 2007-02-14 | 陈彦方 | 一种治疗失眠的黑白制剂 |
AR056076A1 (es) * | 2005-09-20 | 2007-09-19 | Takeda Pharmaceutical | Agente profilactico o terapeutico para el desorden de sueno |
CN102018681A (zh) * | 2010-12-10 | 2011-04-20 | 荣港生技医药科技(北京)有限公司 | 一种美乐托宁缓释剂、其制备方法及其应用 |
US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
US9532952B2 (en) * | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
EP2570126B1 (en) | 2011-09-16 | 2014-03-26 | Darius Rassoulian | Use of melatonin for treating acute alcohol intoxication |
US10849856B2 (en) | 2016-10-31 | 2020-12-01 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
MX2019004736A (es) | 2016-10-31 | 2019-06-17 | Neurim Pharma 1991 | Mini-tabletas de melatonina y metodos de fabricacion de las mismas. |
CN109364031A (zh) * | 2018-10-07 | 2019-02-22 | 威海贯标信息科技有限公司 | 一种盐酸曲唑酮片剂组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4600723A (en) * | 1983-05-18 | 1986-07-15 | Monash University | Method for minimizing disturbances in circadian rhythms of bodily performance and function |
US5707652A (en) * | 1990-12-04 | 1998-01-13 | State Of Oregon | Methods of treating circadian rhythm phase disorders |
IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
FR2718020B1 (fr) * | 1994-04-01 | 1996-05-31 | Biotec Centre Sa | Composition galénique mucoadhésive hétérofonctionnelle. |
WO1996023496A1 (en) * | 1995-02-01 | 1996-08-08 | Neurim Pharmaceuticals (1991) Ltd. | Use of melatonin for treating patients suffering from drug addiction |
CN100443480C (zh) * | 1996-03-08 | 2008-12-17 | 武田药品工业株式会社 | 三环化合物及其制备和用途 |
AU2583397A (en) * | 1996-04-10 | 1997-10-29 | Chronorx, Llc | Unit dosage forms, containing magnesium, vitamin c, vitamin e, folate and selenium, for treatment of vasoconstriction and related conditions |
WO1998002158A1 (en) | 1996-07-17 | 1998-01-22 | Merck & Co., Inc. | Alteration of circadian rhythmicity with a tachykinin antagonist |
CN1206996C (zh) * | 1998-06-09 | 2005-06-22 | 武田药品工业株式会社 | 用于治疗或预防睡眠障碍的药物组合物 |
CN1131030C (zh) * | 1999-03-18 | 2003-12-17 | 胡秀云 | 一种由褪黑素和安定制成的调节睡眠的组合物 |
BR0009200A (pt) * | 1999-03-22 | 2001-12-26 | Immugen Pharmaceuticals Inc | Compostos e composições para o tratamento dedoenças associada com disfunção imune |
IL144900A (en) * | 2001-08-14 | 2013-12-31 | Neurim Pharma 1991 | Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs |
-
2002
- 2002-04-28 IL IL149377A patent/IL149377A/en active IP Right Grant
-
2003
- 2003-03-17 GT GT200300064A patent/GT200300064A/es unknown
- 2003-03-20 CA CA2477516A patent/CA2477516C/en not_active Expired - Lifetime
- 2003-03-20 DE DE60336999T patent/DE60336999D1/de not_active Expired - Lifetime
- 2003-03-20 PL PL372867A patent/PL209922B1/pl unknown
- 2003-03-20 DK DK03746393.2T patent/DK1494650T3/da active
- 2003-03-20 MX MXPA04009893A patent/MXPA04009893A/es active IP Right Grant
- 2003-03-20 BR BR0308762-0A patent/BR0308762A/pt not_active Application Discontinuation
- 2003-03-20 CN CNB038075644A patent/CN100386070C/zh not_active Expired - Lifetime
- 2003-03-20 KR KR1020047015934A patent/KR101000624B1/ko active IP Right Grant
- 2003-03-20 EA EA200401331A patent/EA007954B1/ru not_active IP Right Cessation
- 2003-03-20 NZ NZ536298A patent/NZ536298A/en not_active IP Right Cessation
- 2003-03-20 US US10/510,625 patent/US20050175692A1/en not_active Abandoned
- 2003-03-20 AT AT03746393T patent/ATE507831T1/de active
- 2003-03-20 JP JP2003583375A patent/JP2005527583A/ja active Pending
- 2003-03-20 PE PE2003000278A patent/PE20040161A1/es not_active Application Discontinuation
- 2003-03-20 WO PCT/IL2003/000240 patent/WO2003086352A1/en active Application Filing
- 2003-03-20 ES ES03746393T patent/ES2366116T3/es not_active Expired - Lifetime
- 2003-03-20 UA UA20041008558A patent/UA86924C2/ru unknown
- 2003-03-20 PT PT03746393T patent/PT1494650E/pt unknown
- 2003-03-20 AU AU2003227304A patent/AU2003227304B2/en not_active Expired
- 2003-03-20 EP EP03746393A patent/EP1494650B1/en not_active Expired - Lifetime
- 2003-04-01 TW TW092107377A patent/TW200305404A/zh unknown
- 2003-04-02 AR ARP030101156A patent/AR039232A1/es not_active Application Discontinuation
- 2003-04-07 UY UY27753A patent/UY27753A1/es not_active Application Discontinuation
- 2003-04-07 HN HN2003000115A patent/HN2003000115A/es unknown
-
2004
- 2004-08-27 NO NO20043576A patent/NO332525B1/no not_active IP Right Cessation
- 2004-09-21 ZA ZA2004/07563A patent/ZA200407563B/en unknown
- 2004-10-07 IS IS7492A patent/IS2858B/is unknown
-
2005
- 2005-09-05 HK HK05107777A patent/HK1075616A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1501534E (pt) | Formulacoes farmaceuticas | |
NO20033384D0 (no) | Farmasöytisk formulering | |
DK3494995T3 (da) | Superfin formoterolformulering | |
DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
NO20033785L (no) | Farmasöytisk formulering | |
ATE380544T1 (de) | Umhüllte feste darreichungsform | |
DK1620118T3 (da) | Reversible pegylerede lægemidler | |
IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
DE602004017700D1 (de) | Transmukosen verabreichung | |
NO20052952D0 (no) | Farmasoytisk sammensetning som innbefatter mikropartikler | |
DK1425019T3 (da) | Farmaceutisk sammensætning omfattende et androgen | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
IS7715A (is) | Nýjar lyfjasamsetningar úr módafíníl | |
NO20035627D0 (no) | Farmasöytisk formulering | |
NO20050689L (no) | Terapeutisk anvendelse | |
DK1596870T3 (da) | Höjdosis-iblandronatformulering | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
ATA8202001A (de) | Medikamentenapplikator | |
DE10393889D2 (de) | Medikament-Dosimeter-Kombipackung | |
ITMI20020921A1 (it) | Dispositivo per la sommistrazione di farmaci | |
NO20044164L (no) | Farmasoytiske sammensetninger | |
DE50313285D1 (de) | Melatonin-tagesdosierungseinheiten | |
DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
SE0200449D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |